Håndtering af hjertekomplikationer sekundært til medicinsk kræftbehandling

Ann Banke, Anne Polk, Dorte Nielsen, Lars Videbæk, Ulrik Overgaard, Emil Loldrup Fosbøl, Merete Vaage-Nilsen, Kirsten Melgaard Nielsen, Morten Schou

Abstract

As the prognoses of both heart and cancer patients have improved along with a longer life expectancy in the general population, the prevalence of both heart- and cancer diseases is increasing. Thus, a larger proportion of cancer patients will have cardiovascular co-morbidity and an increased risk of cardiovascular complications during and after cancer treatment. In this article, the current knowledge on the prevention, monitoring and treatment of cardiotoxicity induced by medical anti-cancer treatment with focus on anthracyclines, trastuzumab and 5-fluorouracil is described.

Bidragets oversatte titelManagement of cardiovascular complications secondary to medical treatment of cancer
OriginalsprogDansk
ArtikelnummerV0417026
TidsskriftUgeskrift for Laeger
Vol/bind180
Udgave nummer7
Sider (fra-til)2-6
ISSN0041-5782
StatusUdgivet - 12 feb. 2018

Fingeraftryk

Dyk ned i forskningsemnerne om 'Håndtering af hjertekomplikationer sekundært til medicinsk kræftbehandling'. Sammen danner de et unikt fingeraftryk.

Citationsformater